We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$654B
AUM Growth
+$24.9B
Cap. Flow
-$1.63B
Cap. Flow %
-0.25%
Top 10 Hldgs %
20.75%
Holding
2,648
New
98
Increased
1,625
Reduced
741
Closed
68

Top Sells

Rank Stock Value
1
YUM icon
Yum! Brands
YUM
+$1.4B
2
AAPL icon
Apple
AAPL
+$1.26B
3
TSLA icon
Tesla
TSLA
+$1.13B
4
JPM icon
JPMorgan Chase
JPM
+$1.11B
5
MS icon
Morgan Stanley
MS
+$1.1B

Sector Composition

Rank Sector Weight
1 Technology 16.93%
2 Healthcare 16.29%
3 Consumer Discretionary 15.16%
4 Financials 15.14%
5 Communication Services 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXE
2401
DELISTED
Anixter International Inc
AXE
$239K ﹤0.01%
3,773
+44
+1% +$2.94K
TTPH
2402
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$237K ﹤0.01%
3,315
+5
+0.2% +$353
GTES icon
2403
Gates Industrial Corporation Ltd.
GTES
$7.05B
$236K ﹤0.01%
+14,504
New +$229K
OLP
2404
One Liberty Properties
OLP
$523M
$236K ﹤0.01%
+8,944
New +$222K
AD
2405
Array Digital Infrastructure
AD
$3.04B
$236K ﹤0.01%
+6,359
New +$241K
HRG
2406
DELISTED
HRG Group, Inc.
HRG
$236K ﹤0.01%
18,048
+264
+1% +$3.52K
NNI icon
2407
Nelnet
NNI
$4.52B
$235K ﹤0.01%
4,026
+21
+0.5% +$1.21K
IRT icon
2408
Independence Realty Trust
IRT
$3.96B
$234K ﹤0.01%
22,695
+146
+0.6% +$1.41K
MITK icon
2409
Mitek Systems
MITK
$838M
$234K ﹤0.01%
26,279
+38
+0.1% +$321
RDNT icon
2410
RadNet
RDNT
$6.06B
$234K ﹤0.01%
15,623
+51
+0.3% +$693
TCRT icon
2411
Alaunos Therapeutics
TCRT
$4.88M
$234K ﹤0.01%
516
+6
+1% +$3.81K
AAOI icon
2412
Applied Optoelectronics
AAOI
$11.7B
$233K ﹤0.01%
+5,197
New +$185K
MXWL
2413
DELISTED
Maxwell Technologies Inc
MXWL
$233K ﹤0.01%
44,757
+100
+0.2% +$543
GIC icon
2414
Global Industrial
GIC
$1.49B
$232K ﹤0.01%
+6,757
New +$216K
GCAP
2415
DELISTED
Gain Capital Holdings, Inc.
GCAP
$232K ﹤0.01%
30,704
+37
+0.1% +$293
INFI
2416
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$230K ﹤0.01%
120,206
+43,300
+56% +$87.5K
NSSC icon
2417
Napco Security Technologies
NSSC
$1.39B
$228K ﹤0.01%
31,142
NFBK
2418
DELISTED
Northfield Bancorp
NFBK
$227K ﹤0.01%
13,646
+47
+0.3% +$761
TPCO
2419
DELISTED
Tribune Publishing Company Common Stock
TPCO
$225K ﹤0.01%
13,016
+22
+0.2% +$384
CIVI
2420
DELISTED
Civitas Resources
CIVI
$224K ﹤0.01%
+5,909
New +$190K
DMK
2421
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$223K ﹤0.01%
997
FNJN
2422
DELISTED
Finjan Holdings, Inc.
FNJN
$223K ﹤0.01%
65,450
+200
+0.3% +$599
AKBA icon
2423
Akebia Therapeutics
AKBA
$248M
$222K ﹤0.01%
22,293
+107
+0.5% +$1.07K
VSEC icon
2424
VSE Corp
VSEC
$6.81B
$222K ﹤0.01%
4,650
+9
+0.2% +$452
HSKA
2425
DELISTED
Heska Corp
HSKA
$222K ﹤0.01%
+2,137
New +$200K

Similar funds

T. Rowe Price Associates's Q2 2018 Portfolio in Review

As of Q2 2018, T. Rowe Price Associates held 2,648 positions worth $654B, up 4% from $629B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates's Q2 2018 filing shows 98 new, 1,625 increased, 741 reduced and 68 closed positions. Its largest new stake was Evergy: 16,595,898 shares worth $932M. The largest sale was Yum! Brands, an estimated $1.4B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2018 buy was Evergy: 16,595,898 shares worth $932M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q2 2018, an estimated $1.62B increase.
  • T. Rowe Price Associates's biggest Q2 2018 reduction was Yum! Brands, cutting an estimated $1.4B.
  • T. Rowe Price Associates fully exited CSRA Inc. in Q2 2018, selling an estimated $912M.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $654B portfolio in Q2 2018.
  • T. Rowe Price Associates opened 98 new positions and closed 68 in Q2 2018.
  • T. Rowe Price Associates's portfolio value rose 4% quarter-over-quarter to $654B.

Based on T. Rowe Price Associates's 13F filing for Q2 2018, filed 14 Aug 2018.